Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 327

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease

Open access
Lozano, Andres M., Fosdick, Lisa, Chakravarty, M. Mallar, Leoutsakos, Jeannie-Marie, Munro, Cynthia, Oh, Esther, Drake, Kristen E., Lyman, Christopher H., Rosenberg, Paul B., Anderson, William S., Tang-Wai, David F., Pendergrass, Jo Cara, Salloway, Stephen, Asaad, Wael F., Ponce, Francisco A., Burke, Anna, Sabbagh, Marwan, Wolk, David A., Baltuch, Gordon, Okun, Michael S., Foote, Kelly D., McAndrews, Mary Pat, Giacobbe, Peter, Targum, Steven D., Lyketsos, Constantine G., Smith, Gwenn S.·2016·Journal of Alzheimer's Disease

Abstract

BACKGROUND: Deep brain stimulation (DBS) is used to modulate the activity of dysfunctional brain circuits. The safety and efficacy of DBS in dementia is unknown. OBJECTIVE: To assess DBS of memory circuits as a treatment for patients with mild Alzheimer's disease (AD). METHODS: We evaluated active "on" versus sham "off" bilateral DBS directed at the fornix-a major fiber bundle in the brain's memory circuit-in a randomized, double-blind trial (ClinicalTrials.gov NCT01608061) in 42 patients with mild AD. We measured cognitive function and cerebral glucose metabolism up to 12 months post-implantation. RESULTS: Surgery and electrical stimulation were safe and well tolerated. There were no significant differences in the primary cognitive outcomes (ADAS-Cog 13, CDR-SB) in the "on" versus "off" stimulation group at 12 months for the whole cohort. Patients receiving stimulation showed increased metabolism at 6 months but this was not significant at 12 months. On post-hoc analysis, there was a significant interaction between age and treatment outcome: in contrast to patients <65 years old (n = 12) whose results trended toward being worse with DBS ON versus OFF, in patients≥65 (n = 30) DBS-f ON treatment was associated with a trend toward both benefit on clinical outcomes and a greater increase in cerebral glucose metabolism. CONCLUSION: DBS for AD was safe and associated with increased cerebral glucose metabolism. There were no differences in cognitive outcomes for participants as a whole, but participants aged≥65 years may have derived benefit while there was possible worsening in patients below age 65 years with stimulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-160017

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 327

Metadata

Authors
Lozano, A. M., Fosdick, L., Chakravarty, M. M., Leoutsakos, J.-M., Munro, C., Oh, E., Drake, K. E., Lyman, C. H., Rosenberg, P. B., Anderson, W. S., Tang-Wai, D. F., Pendergrass, J. C., Salloway, S., Asaad, W. F., Ponce, F. A., Burke, A., Sabbagh, M., Wolk, D. A., Baltuch, G., Okun, M. S., Foote, K. D., McAndrews, M. P., Giacobbe, P., Targum, S. D., Lyketsos, C. G., & Smith, G. S.
Venue
Journal of Alzheimer's Disease
Published
2016-09-06
Volume
54
Issue
2
Pages
777-787
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2503910289
Cited by
327
References
29
FWCI
22.74
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease. https://app.cochat.ai/papers/10.3233/jad-160017
The paper
Lozano, A. M., Fosdick, L., Chakravarty, M. M., Leoutsakos, J.-M., Munro, C., Oh, E., Drake, K. E., Lyman, C. H., Rosenberg, P. B., Anderson, W. S., Tang-Wai, D. F., Pendergrass, J. C., Salloway, S., Asaad, W. F., Ponce, F. A., Burke, A., Sabbagh, M., Wolk, D. A., Baltuch, G., . . . Smith, G. S. (2016). A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-160017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.